Page 309 - medicina-integrativa_compress

CAPÍTULO 28 CARDIOPATÍA ISQUÉMICA 305

73. Mozaffarian D, Ascherio A, Hu FB, et al: Interplay between different hypercholesterolemia and noninsulin-dependent diabetes mellitus.
polyunsaturated fatty acids and risk of coronary heart disease in men. Int J Clin Pharmacol Res 19:117-127, 1999.
Circulation 111:157-164, 2005. 86. Carbajal D, Arruzazabala ML, Valdes S, Mas R: Effect of policosanol
74. Buckley MS, Goff AD, Knapp WE: Fish oil interaction with warfarin. on platelet aggregation and serum levels of arachidonic acid
Ann Pharmacother 38:50-52, 2004. metabolites in healthy volunteers. Prostaglandins Leukot Essent Fatty
75. NCEP: Executive Summary of The Third Report of The National Acids 58:61-64, 1998.
Cholesterol Education Program (NCEP) Expert Panel on Detection, 87. Wald NJ, Law MR: A strategy to reduce cardiovascular disease by
Evaluation, and Treatment of High Blood Cholesterol in Adults more than 80%. BMJ 326:1419, 2003.
(Adult Treatment Panel III). JAMA 285:2486-2497, 2001. 88. Jochmann N, Stangl K, Garbe E, et al: Female-specific aspects in the
76. Moreyra AE, Wilson AC, Koraym A: Effect of combining psyllium pharmacotherapy of chronic cardiovascular diseases. Eur Heart J
fiber with simvastatin in lowering cholesterol. Arch Intern Med 26:1585-1595, 2005.
165:1161-1166, 2005. 89. Yusuf S: Two decades of progress in preventing vascular disease.
77. Pittler MH, Thompson CO, Ernst E: Artichoke leaf extract for Lancet 360:2-3, 2002.
treating hypercholesterolaemia. Cochrane Database Syst Rev 90. Freemantle N, Cleland J, Young P, et al: Beta blockade after
(3)CD003335, 2002. myocardial infarction: Systematic review and meta regression
78. Englisch W, Beckers C, Unkauf M, et al: Efficacy of artichoke dry analysis. BMJ 318:1730-1737, 1999.
extract in patients with hyperlipoproteinemia. Arzneimittelforschung 91. O'Keefe JH, Wetzel M, Moe RR, et al: Should an angiotensin-
50:260-265, 2000. converting enzyme inhibitor be standard therapy for patients with
79. Steiner M, Lin RS: Changes in platelet function and susceptibility of atherosclerotic disease? J Am Coll Cardiol 37:1-8, 2001.
lipoproteins to oxidation associated with administration of aged 92. Yusuf S, Sleight P, Pogue J, et al: Effects of an angiotensin-
garlic extract. J Cardiovasc Pharmacol 31:904-908, 1998. converting-enzyme inhibitor, ramipril, on cardiovascular events in
80. Ide N, Lau BH: Garlic compounds minimize intracellular oxidative high-risk patients. The Heart Outcomes Prevention Evaluation Study
stress and inhibit nuclear factor-kappa b activation. J Nutr Investigators. N Engl J Med 342:145-153, 2000.
131(Suppl):1020S-1026S, 2001. 93. HPS. MRC/BHF Heart Protection Study of cholesterol lowering with
81. Blumenthal M: Herbal Medicine: Expanded Commission E simvastatin in 20,536 high-risk individuals: A randomised placebo-
Monographs. Newton, MA, Integrative Medicine Communications, controlled trial. Lancet 360:7-22, 2002.
2000. 94. Villarruz MV, Dans A, Tan F: Chelation therapy for atherosclerotic
82. Freedman JE, Parker C III, Li L, et al: Select flavonoids and whole cardiovascular disease. Cochrane Database Syst Rev (4)CD002785,
juice from purple grapes inhibit platelet function and enhance nitric 2002.
oxide release. Circulation 103:2792-2798, 2001. 95. Chao DM, Shen LL, Tjen ALS, et al: Naloxone reverses inhibitory
83. Pittler MH, Schmidt K, Ernst E: Hawthorn extract for treating effect of electroacupuncture on sympathetic cardiovascular reflex
chronic heart failure: Meta-analysis of randomized trials. Am J Med responses. Am J Physiol 276:H2127-H2134, 1999.
114:665-674, 2003. 96. Ballegaard S, Meyer CN, Trojaborg W: Acupuncture in angina
84. Gouni-Berthold I, Berthold HK: Policosanol: Clinical pharmacology pectoris: Does acupuncture have a specific effect? J Intern Med
and therapeutic significance of a new lipid-lowering agent. Am Heart 229:357-362, 1991.
J 143:356-365, 2002. 97. Fairfield KM, Fletcher RH: Vitamins for chronic disease
85. Crespo N, Illnait J, Mas R, et al: Comparative study of the efficacy prevention in adults: Scientific review. JAMA 287:3116-3126,
and tolerability of policosanol and lovastatin in patients with 2002.

© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.